Long v short half-life benzodiazepines in the elderly. Kinetics and clinical effects of diazepam and oxazepam. 1983

C Salzman, and R I Shader, and D J Greenblatt, and J S Harmatz

Oxazepam and diazepam were compared in healthy elderly volunteers. Absorption of diazepam was faster than oxazepam and onset of clinical effects were more profound. Diazepam accumulation was extensive, washout was slow and active compounds were present two weeks after the last dose. Oxazepam accumulation was significantly less and elimination significantly faster than diazepam. There was no difference between oxazepam and diazepam in sedation or fatigue during the drug treatment, but sedative effects persisted for two weeks after diazepam therapy was discontinued. Sedation rapidly returned to baseline in the oxazepam group. Thus, the differing pharmacokinetic profiles of diazepam and oxazepam have clinical consequences during multiple dosage in the elderly.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010076 Oxazepam A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia. Adumbran,Serax,Tazepam
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005221 Fatigue The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli. Lassitude
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C Salzman, and R I Shader, and D J Greenblatt, and J S Harmatz
April 1977, Journal of pharmaceutical sciences,
C Salzman, and R I Shader, and D J Greenblatt, and J S Harmatz
April 1984, Rational drug therapy,
C Salzman, and R I Shader, and D J Greenblatt, and J S Harmatz
December 1988, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
C Salzman, and R I Shader, and D J Greenblatt, and J S Harmatz
December 1989, JAMA,
C Salzman, and R I Shader, and D J Greenblatt, and J S Harmatz
July 1986, Ugeskrift for laeger,
C Salzman, and R I Shader, and D J Greenblatt, and J S Harmatz
January 1977, Acta pharmacologica et toxicologica,
C Salzman, and R I Shader, and D J Greenblatt, and J S Harmatz
May 1970, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
C Salzman, and R I Shader, and D J Greenblatt, and J S Harmatz
December 1967, Arzneimittel-Forschung,
C Salzman, and R I Shader, and D J Greenblatt, and J S Harmatz
July 1970, Actas luso-espanolas de neurologia y psiquiatria,
C Salzman, and R I Shader, and D J Greenblatt, and J S Harmatz
January 1984, Current medical research and opinion,
Copied contents to your clipboard!